These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15528744)

  • 1. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.
    Tsang RS; Lau AK; Sill ML; Halperin SA; Van Caeseele P; Jamieson F; Martin IE
    J Clin Microbiol; 2004 Nov; 42(11):5364-7. PubMed ID: 15528744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
    Tsang RS; Sill ML; Martin IE; Jamieson F
    Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small mutations in Bordetella pertussis are associated with selective sweeps.
    van Gent M; Bart MJ; van der Heide HG; Heuvelman KJ; Mooi FR
    PLoS One; 2012; 7(9):e46407. PubMed ID: 23029513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation.
    Niinikoski V; Barkoff AM; Mertsola J; He Q
    Clin Microbiol Infect; 2024 May; 30(5):683.e1-683.e3. PubMed ID: 38310999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
    Queenan AM; Dowling DJ; Cheng WK; Faé K; Fernandez J; Flynn PJ; Joshi S; Brightman SE; Ramirez J; Serroyen J; Wiertsema S; Fortanier A; van den Dobbelsteen G; Levy O; Poolman J
    Vaccine; 2019 Jan; 37(1):80-89. PubMed ID: 30478007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population diversity among Bordetella pertussis isolates, United States, 1935-2009.
    Schmidtke AJ; Boney KO; Martin SW; Skoff TH; Tondella ML; Tatti KM
    Emerg Infect Dis; 2012 Aug; 18(8):1248-55. PubMed ID: 22841154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
    Shinkarev AS; Mertsalova NU; Mazurova IK; Borisova OIu; Zakharova NS; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Britsina MV; Bazhanova IG
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):20-5. PubMed ID: 17886371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.
    Hallander H; Advani A; Alexander F; Gustafsson L; Ljungman M; Pratt C; Hall I; Gorringe AR
    Clin Vaccine Immunol; 2014 Feb; 21(2):165-73. PubMed ID: 24307240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
    Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
    Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antigenic variability of Bordetella pertussis strains isolated in 1967-2010 in the Czech Republic--possible explanation for the rise in cases of pertussis?].
    Zavadilová J; Lžičařová D; Musílek M; Křížová P; Fabiánová K
    Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):130-8. PubMed ID: 26448300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis, Finland and France.
    Caro V; Elomaa A; Brun D; Mertsola J; He Q; Guiso N
    Emerg Infect Dis; 2006 Jun; 12(6):987-9. PubMed ID: 16707058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
    Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
    J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis.
    Oguchi K; Miyata A; Kazuyama Y; Noda A; Suzuki E; Watanabe M; Nakayama T
    J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.
    Tsang RS; Shuel M; Jamieson FB; Drews S; Hoang L; Horsman G; Lefebvre B; Desai S; St-Laurent M
    Int J Infect Dis; 2014 Nov; 28():65-9. PubMed ID: 25244999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertactin-deficient
    Barkoff AM; Mertsola J; Pierard D; Dalby T; Hoegh SV; Guillot S; Stefanelli P; van Gent M; Berbers G; Vestrheim D; Greve-Isdahl M; Wehlin L; Ljungman M; Fry NK; Markey K; He Q
    Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children.
    Mastrantonio P; Spigaglia P; Oirschot HV; van der Heide HGJ; Heuvelman K; Stefanelli P; Mooi FR
    Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2069-2075. PubMed ID: 10463173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.
    Fry NK; Neal S; Harrison TG; Miller E; Matthews R; George RC
    Infect Immun; 2001 Sep; 69(9):5520-8. PubMed ID: 11500425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.